title: Chemo-enzymatic synthesis of the carbohydrate antigen N-glycolylneuraminic acid from glucose.
abstract: N-Glycolylneuraminic acid (Neu5Gc) is a non-human sialic acid, which may play a significant role in human pathologies, such as cancer and vascular disease. Further studies into the role of Neu5Gc in human disease are hindered by limited sources of this carbohydrate. Using a chemo-enzymatic approach, Neu5Gc was accessed in six steps from glucose. The synthesis allows access to gram-scale quantities quickly and economically and produces Neu5Gc in superior quality to commercial sources. Finally, we demonstrate that the synthesized Neu5Gc can be incorporated into the cell glycocalyx of human cells, which do not naturally synthesize this sugar. The synthesis produces Neu5Gc suitable for in vitro or in vivo use.
authors.affiliation: Department of Cellular and Molecular Medicine, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0687, USA.
authors.forename: Oliver M T
authors.initials: OM
authors.lastname: Pearce
authors.forename: Ajit
authors.initials: A
authors.lastname: Varki
mesh_terms: D000941:Antigens / Q000737:chemistry / Q000378:metabolism*; D002460:Cell Line; D004798:Enzymes / Q000378:metabolism*; D005947:Glucose / Q000737:chemistry* / Q000378:metabolism; D019276:Glycocalyx / Q000378:metabolism; D006801:Humans; D009438:Neuraminic Acids / Q000138:chemical synthesis* / Q000737:chemistry / Q000378:metabolism*; D016979:Pasteurella multocida / Q000201:enzymology
chemical_list: D000941:Antigens; D004798:Enzymes; D009438:Neuraminic Acids; C032592:N-glycolylneuraminic acid; D005947:Glucose
references.citation: J Biotechnol. 2008 Apr 30;134(3-4):261-5
references.pmid: 18378033
references.citation: Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18936-41
references.pmid: 19017806
references.citation: Appl Microbiol Biotechnol. 2008 Jul;79(6):963-70
references.pmid: 18521592
references.citation: Org Lett. 2000 Apr 6;2(7):891-4
references.pmid: 10768179
references.citation: Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12045-50
references.pmid: 14523234
references.citation: J Org Chem. 1996 Dec 13;61(25):8739-8745
references.pmid: 11667846
references.citation: BMC Biotechnol. 2009 Jul 09;9:63
references.pmid: 19586552
references.citation: Trends Mol Med. 2008 Aug;14(8):351-60
references.pmid: 18606570
references.citation: Angew Chem Int Ed Engl. 2006 Nov 13;45(44):7417-21
references.pmid: 17031889
references.citation: Bioorg Med Chem. 2002 Oct;10(10):3175-85
references.pmid: 12150863
references.citation: Chem Biol. 2005 Jun;12(6):677-83
references.pmid: 15975513
references.citation: J Am Chem Soc. 2005 Apr 13;127(14):5004-5
references.pmid: 15810819
references.citation: PLoS One. 2009;4(1):e4241
references.pmid: 19156207
references.citation: Carbohydr Res. 2008 Aug 11;343(12):2075-82
references.pmid: 18353292
references.citation: Angew Chem Int Ed Engl. 2007;46(13):2249-53
references.pmid: 17309109
references.citation: J Biol Chem. 2005 Feb 11;280(6):4228-37
references.pmid: 15557321
references.citation: Nature. 2007 Apr 26;446(7139):1023-9
references.pmid: 17460663
references.citation: Blood. 2009 Dec 10;114(25):5225-35
references.pmid: 19828701
references.citation: Nat Rev Immunol. 2007 Apr;7(4):255-66
references.pmid: 17380156
references.citation: Blood. 2007 May 15;109(10):4280-7
references.pmid: 17272508